Shenzhen, China

Zehao Liao

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Longuide Biopharma Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zehao Liao. Retrieved from https://idiyas.com/inventor/zehao-liao-43sl01i0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zehao Liao - Innovator in Lipid Nanoparticle Formulations

Introduction

Zehao Liao is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of lipid nanoparticle formulations. His work focuses on innovative methods for delivering nucleic acids, such as mRNA, which are crucial for various therapeutic applications.

Latest Patents

Zehao Liao holds 1 patent related to lipids and lipid nanoparticle formulations. This patent outlines methods for using these formulations to effectively deliver nucleic acids, enhancing the potential for mRNA therapies.

Career Highlights

Liao is currently associated with Longuide Biopharma Corporation, where he applies his expertise in lipid formulations to advance biopharmaceutical technologies. His work is instrumental in the ongoing research and development efforts within the company.

Collaborations

He collaborates with notable colleagues, including Longgui Zhang and Yuebao Zhang, contributing to a dynamic research environment that fosters innovation in biopharmaceuticals.

Conclusion

Zehao Liao's contributions to lipid nanoparticle formulations represent a significant advancement in the delivery of nucleic acids for therapeutic purposes. His work continues to influence the field of biopharmaceuticals, paving the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…